Shares of DexCom Inc. DXCM inched 0.12% higher to $81.01 Wednesday, on what proved to be an all-around positive trading ...

The CGM market is practically a duopoly that DexCom shares with Abbott Laboratories. DexCom's success in this market explains ...

器械之家医疗器械媒体报道先锋分享专业医疗器械知识关注 来源：器械之家，未经授权不得转载，且24小时后方可转载近日，全球领先的连续血糖监测仪（CGM）龙头Dexcom宣布，已向智能戒指制造商Ōura投资7500万美元（约折合5.4亿人民币），并达成战略 ...

Shares of DexCom Inc. DXCM rose 2.02% to $80.91 Tuesday, on what proved to be an all-around mixed trading session for the ...

DexCom的地位尤为引人注目，因为它在大盘股中脱颖而出，目前交易价格比52周高点低49%，而大多数大盘成长股仅比52周高点低1-3%。美银证券指出，如果公司的执行符合2025年的预期，DexCom提供了更大的估值倍数扩张潜力。

Oura has become incredibly popular in the last few years. The company, originally from Finland, launched its first wearable ...

据 TechCrunch 报道，智能戒指制造商 Oura 宣布于周二获得了来自血糖设备制造商 Dexcom 的 7500 万美元投资。这笔投资标志着 Oura 的 D 轮融资，使公司的估值超过 50 亿美元。 “97%的 Oura ...

“行业观察者”是我们针对人工智能、XR、元宇宙和Web3等前沿科技而设立的专栏，主要分享这些领域中的新兴企业或者创业者们的故事。智能戒指制造商Oura获得了美国连续血糖监测（CGM）巨头Dexcom领投的7500万美元融资，并建立战略合作伙伴关系，现 ...

Dexcom Inc. (NASDAQ:DXCM) 近期报告了一项涉及其执行副总裁兼首席人力资源官Sadie Stern的股票交易。根据SEC Form 4文件显示，Stern于2024年11月20日以每股74.73美元的价格出售了4,259股普通股。此次出售的总价值为318,275美元。

On Friday, DexCom Inc (DXCM) stock saw a decline, ending the day at $77.5 which represents a decrease of $-0.60 or -0.77% from the prior close of $78.1. The stock opened at $78.4 and touched a low of ...

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Dexcom (DXCM – Research Report) yesterday and set a price target of $90.00. The ...